Dawn E. Post

1.5k total citations
18 papers, 1.2k citations indexed

About

Dawn E. Post is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Dawn E. Post has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Genetics and 6 papers in Oncology. Recurrent topics in Dawn E. Post's work include Virus-based gene therapy research (9 papers), Cancer Research and Treatments (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Dawn E. Post is often cited by papers focused on Virus-based gene therapy research (9 papers), Cancer Research and Treatments (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Dawn E. Post collaborates with scholars based in United States, Canada and Singapore. Dawn E. Post's co-authors include Erwin G. Van Meir, Jonathan W. Simons, Fadlo R. Khuri, Hua Zhong, Daniel J. Brat, Balveen Kaur, Nicola J. Mabjeesh, Margaret Willard, Roland Chu and Donald L. Durden and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Dawn E. Post

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dawn E. Post United States	14	727	499	387	348	155	18	1.2k
Habib Fakhrai United States	19	990 1.4×	250 0.5×	140 0.4×	1.1k 3.2×	213 1.4×	35	2.1k
Futoshi Uno Japan	20	784 1.1×	549 1.1×	200 0.5×	579 1.7×	409 2.6×	46	1.4k
Gail Eckhardt United States	12	850 1.2×	319 0.6×	273 0.7×	900 2.6×	170 1.1×	20	1.6k
Sunita Shankar United States	11	1.6k 2.2×	131 0.3×	873 2.3×	317 0.9×	43 0.3×	21	2.0k
Despina Siolas United States	8	674 0.9×	145 0.3×	301 0.8×	465 1.3×	115 0.7×	21	1.2k
Avi Shvarts Netherlands	11	717 1.0×	183 0.4×	491 1.3×	532 1.5×	151 1.0×	18	1.1k
Richard K. Rosenberg United States	9	792 1.1×	207 0.4×	340 0.9×	853 2.5×	193 1.2×	11	1.4k
Linda C. Harris United States	22	1.2k 1.6×	164 0.3×	349 0.9×	522 1.5×	68 0.4×	44	1.4k
Leandros-Vassilios Vassiliou United Kingdom	3	1.4k 1.9×	180 0.4×	297 0.8×	734 2.1×	61 0.4×	4	1.6k
Esther R. Allay United States	16	954 1.3×	384 0.8×	229 0.6×	292 0.8×	34 0.2×	17	1.3k

Countries citing papers authored by Dawn E. Post

Since Specialization

Citations

This map shows the geographic impact of Dawn E. Post's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn E. Post with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn E. Post more than expected).

Fields of papers citing papers by Dawn E. Post

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn E. Post. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn E. Post. The network helps show where Dawn E. Post may publish in the future.

Co-authorship network of co-authors of Dawn E. Post

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn E. Post. A scholar is included among the top collaborators of Dawn E. Post based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn E. Post. Dawn E. Post is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Backe, Sarah J., Rebecca Sager, Michael Daneshvar, et al.. (2026). Targeting and dissociating HIF2α from the molecular chaperone Hsp70 triggers apoptosis in kidney cancer. Communications Medicine. 6(1). 91–91.

Li, Xiang, Dawn E. Post, Ming Chen, et al.. (2019). Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling. Cell Communication and Signaling. 17(1). 120–120. 32 indexed citations

Li, Xiang, Dawn E. Post, Ming Chen, et al.. (2019). Abi1 loss drives prostate tumorigenesis through activation of EMT and noncanonical WNT signaling.. Journal of Clinical Oncology. 37(7_suppl). 280–280. 1 indexed citations

Colicino, Erica G., et al.. (2017). Gravin regulates centrosome function through PLK1. Molecular Biology of the Cell. 29(5). 532–541. 16 indexed citations

Kálmán, Bernadette, et al.. (2013). Epidermal Growth Factor Receptor as a Therapeutic Target in Glioblastoma. NeuroMolecular Medicine. 15(2). 420–434. 38 indexed citations

Longo, Sharon L., David J Padalino, Sandra L. B. McGillis, et al.. (2011). Bay846, a new irreversible small molecule inhibitor of EGFR and Her2, is highly effective against malignant brain tumor models. Investigational New Drugs. 30(6). 2161–2172. 8 indexed citations

Longo, S., Christopher C. Griffith, Aaron Glass, Edward J. Shillitoe, & Dawn E. Post. (2010). Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter. Cancer Gene Therapy. 18(2). 123–134. 27 indexed citations

Longo, Sharon L., et al.. (2010). Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy. Gene Therapy. 17(12). 1430–1441. 14 indexed citations

Post, Dawn E., Eric M. Sandberg, Michele Kyle, et al.. (2007). Targeted Cancer Gene Therapy Using a Hypoxia Inducible Factor–Dependent Oncolytic Adenovirus Armed with Interleukin-4. Cancer Research. 67(14). 6872–6881. 90 indexed citations

10.

Rong, Yuan, Dawn E. Post, Russell O. Pieper, et al.. (2005). PTEN and Hypoxia Regulate Tissue Factor Expression and Plasma Coagulation by Glioblastoma. Cancer Research. 65(4). 1406–1413. 190 indexed citations

11.

Post, Dawn E., et al.. (2005). Cancer Scene Investigation: How a Cold Virus Became a Tumor Killer. Future Oncology. 1(2). 247–258. 12 indexed citations

12.

Post, Dawn E., Giulia Fulci, E. Antonio Chiocca, & Erwin G. Van Meir. (2004). Replicative Oncolytic Herpes Simplex Viruses in Combination Cancer Therapies. Current Gene Therapy. 4(1). 41–51. 50 indexed citations

13.

Li, Yang, Ziqin Cao, Dawn E. Post, et al.. (2004). Tumor-specific gene expression using the survivin promoter is further increased by hypoxia. Gene Therapy. 11(15). 1215–1223. 87 indexed citations

14.

Post, Dawn E., Narra S. Devi, Zhenchao Li, et al.. (2004). Cancer Therapy with a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors. Clinical Cancer Research. 10(24). 8603–8612. 50 indexed citations

15.

Chu, Roland, Dawn E. Post, Fadlo R. Khuri, & Erwin G. Van Meir. (2004). Use of Replicating Oncolytic Adenoviruses in Combination Therapy for Cancer. Clinical Cancer Research. 10(16). 5299–5312. 133 indexed citations

16.

Post, Dawn E. & Erwin G. Van Meir. (2003). A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy. Oncogene. 22(14). 2065–2072. 106 indexed citations

17.

Post, Dawn E., Fadlo R. Khuri, Jonathan W. Simons, & Erwin G. Van Meir. (2003). Replicative Oncolytic Adenoviruses in Multimodal Cancer Regimens. Human Gene Therapy. 14(10). 933–946. 62 indexed citations

18.

Mabjeesh, Nicola J., Dawn E. Post, Margaret Willard, et al.. (2002). Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells.. PubMed. 62(9). 2478–82. 253 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact